'Ossiform' is a Danish medical technology company leveraging 3D printing technology to create custom bone implants optimized for each patient. The startup recently raised $6.7 million USD to expand its services in the United States and eventually earn full FDA clearance to begin using its medical solutions.
One benefit of Ossiform over other 3D printing medical companies comes from its materials. The company uses a paste material comprised of beta-tricalcium phosphate and necessary fatty acids, which results in a true bone-like material. The company's motto, as a result, is "we print bone," as opposed to its competitors which use metal and plastic compounds.
In addition to printing shapable bone implants, Ossiform is looking into enhancing its implants with medicine that slowly dissipates into the surrounding area to heal the wound more quickly.
3D-Printed Medical Implants
Ossiform Raised $6.7 Million to Enhance its Printed Bone Implants
Trend Themes
1. 3D Printing in Medical Implants - Ossiform is leveraging 3D printing technology to create custom bone implants optimized for each patient.
2. Customized Medical Solutions - Ossiform's custom bone implants provide a true bone-like material that sets it apart from its competitors.
3. Medicine-enhanced Implants - Ossiform is exploring enhancements to its 3D printed implants to include slowly dissipating medicine to speed up wound healing.
Industry Implications
1. Medical Technology - Ossiform is using 3D printing to disrupt the medical technology industry through creating personalized bone implants.
2. Pharmaceuticals - Ossiform's exploration of medicine-enhanced 3D printed implants present opportunities for disruption in the pharmaceutical industry.
3. Biomedical Engineering - The development of Ossiform's 3D printed bone implants requires innovation in biomedical engineering.